Live Breaking News & Updates on Company To Hold Conference Call Webcast

Longeveron Announces Positive Top-Line Results for Lomecel-B™ in its CLEAR MIND Phase 2a Clinical Trial in the Treatment of Mild Alzheimer's Disease
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Nataliya Agafonova , Jeffrey Cummings , Mike Moyer , Treatment Group Relative To Placebo , Exchange Commission , Company To Hold Conference Call Webcast , Longeveron Inc , Alzheimer Association , International Investors Dial , National Institutes Of Health , Exchange Commission On , Department Of Brain Health , Longeveron Or Company , Announces Positive Top Line Results , Clinical Trial , Mild Alzheimer , Hold Conference Call , Webcast Today , Safety Met Across , Significance Met , Secondary Endpoint Composite Alzheimer , Disease Score , Pooled Lomecel B , Treatment Group Relative , Doses Demonstrated Numerical ,